Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Travel and Tropical Medicine
Questions discussed in this category
How do you factor cerebrospinal fluid (CSF) antibody results when deciding on the diagnosis and treatment of racemose neurocysticercosis, given the uncertainties associated with CSF antibody testing?
1 Answer available
What are your top takeaways from ID Week 2024?
1 Answer available
Are there clinical circumstances in which there is a role for steroids in treatment of calcified neurocysticercosis associated with perilesional edema and seizures?
1 Answer available
Do you routinely refer all patients with cutaneous leishmaniasis with a species associated with mucocutaneous leishmaniasis to ENT for comprehensive nasal/oropharyngeal evaluation, or do you refer only if mucocutaneous involvement is suspected based on careful clinical assessment and/or bedside exam?
1 Answer available
What is your approach to monitoring patients with the indeterminate form of Chagas disease?
1 Answer available
21709
21696
17501
17502
17505
Papers discussed in this category
The Journal of infectious diseases, 2022 May 04
Recommendations for Screening and Diagnosis of Chagas Disease in the United States.
Related Topics
Infectious Disease
Internal Medicine
General Infectious Disease
Neurocysticercosis
Tuberculosis
HIV & AIDS
Non-Tubercular Mycobacteria
Infection Prevention and Control
Transplant Infectious Disease
Sexually Transmitted Diseases